435 related articles for article (PubMed ID: 15283041)
1. PPAR alpha, fibrates, lipid metabolism and inflammation.
Duval C; Fruchart JC; Staels B
Arch Mal Coeur Vaiss; 2004 Jun; 97(6):665-72. PubMed ID: 15283041
[TBL] [Abstract][Full Text] [Related]
2. [Role of the peroxisome proliferator-activated receptors (PPARS) in the regulation of lipids and inflammation control].
Bocher V; Chinetti G; Fruchart JC; Staels B
J Soc Biol; 2002; 196(1):47-52. PubMed ID: 12134632
[TBL] [Abstract][Full Text] [Related]
3. Roles of PPARs in health and disease.
Kersten S; Desvergne B; Wahli W
Nature; 2000 May; 405(6785):421-4. PubMed ID: 10839530
[TBL] [Abstract][Full Text] [Related]
4. [Lipid metabolism related nuclear receptor--the structure, function, expression and classification of peroxisome proliferation-activated receptor (PPAR)].
Kawada T
Nihon Rinsho; 1998 Jul; 56(7):1722-8. PubMed ID: 9702044
[TBL] [Abstract][Full Text] [Related]
5. [Peroxisome proliferator-activated receptors (PPAR) in pathophysiology of the circulatory system and prospective use of agonists of these receptors in therapy].
Bełtowski J; Wójcicka G; Jamroz A
Postepy Hig Med Dosw; 2003; 57(2):199-217. PubMed ID: 12866356
[TBL] [Abstract][Full Text] [Related]
6. [Peroxisome proliferator activated receptors PPARs: their role in carbohydrate and lipid metabolism].
Andrééva-Gatéva P
Ann Biol Clin (Paris); 2003; 61(3):295-303. PubMed ID: 12805006
[TBL] [Abstract][Full Text] [Related]
7. [Molecular nutrition, role of the PPAR system in lipidic metabolism and its importance in obesity and diabetes mellitus].
Uauy R; Martínez JI; Rojas CV
Rev Med Chil; 2000 Apr; 128(4):437-46. PubMed ID: 10962863
[TBL] [Abstract][Full Text] [Related]
8. Peroxisome proliferator-activated receptors (PPARs): nuclear receptors at the crossroads between lipid metabolism and inflammation.
Chinetti G; Fruchart JC; Staels B
Inflamm Res; 2000 Oct; 49(10):497-505. PubMed ID: 11089900
[TBL] [Abstract][Full Text] [Related]
9. PPAR-gamma dependent and independent effects on macrophage-gene expression in lipid metabolism and inflammation.
Chawla A; Barak Y; Nagy L; Liao D; Tontonoz P; Evans RM
Nat Med; 2001 Jan; 7(1):48-52. PubMed ID: 11135615
[TBL] [Abstract][Full Text] [Related]
10. [New concepts on the mechanism of action of fibrates and therapeutic prospectives in atherosclerosis].
Fruchart JC; Staels B; Duriez P
Bull Acad Natl Med; 2001; 185(1):63-74; discussion 74-5. PubMed ID: 11474570
[TBL] [Abstract][Full Text] [Related]
11. [Peroxisome proliferator-activated receptors and atherosclerosis].
Jin N; Wang X
Sheng Li Ke Xue Jin Zhan; 2004 Jan; 35(1):13-8. PubMed ID: 15127591
[TBL] [Abstract][Full Text] [Related]
12. The mechanisms of action of PPARs.
Berger J; Moller DE
Annu Rev Med; 2002; 53():409-35. PubMed ID: 11818483
[TBL] [Abstract][Full Text] [Related]
13. Obesity, peroxisome proliferator-activated receptor, and atherosclerosis in type 2 diabetes.
Blaschke F; Takata Y; Caglayan E; Law RE; Hsueh WA
Arterioscler Thromb Vasc Biol; 2006 Jan; 26(1):28-40. PubMed ID: 16239592
[TBL] [Abstract][Full Text] [Related]
14. Regulatory role of peroxisome proliferator-activated receptor delta (PPAR delta) in muscle metabolism. A new target for metabolic syndrome treatment?
Grimaldi PA
Biochimie; 2005 Jan; 87(1):5-8. PubMed ID: 15733729
[TBL] [Abstract][Full Text] [Related]
15. Weight-loss-associated induction of peroxisome proliferator-activated receptor-alpha and peroxisome proliferator-activated receptor-gamma correlate with reduced atherosclerosis and improved cardiovascular function in obese insulin-resistant mice.
Verreth W; De Keyzer D; Pelat M; Verhamme P; Ganame J; Bielicki JK; Mertens A; Quarck R; Benhabilès N; Marguerie G; Mackness B; Mackness M; Ninio E; Herregods MC; Balligand JL; Holvoet P
Circulation; 2004 Nov; 110(20):3259-69. PubMed ID: 15533870
[TBL] [Abstract][Full Text] [Related]
16. Peroxisome proliferator-activated receptors and inflammation.
Moraes LA; Piqueras L; Bishop-Bailey D
Pharmacol Ther; 2006 Jun; 110(3):371-85. PubMed ID: 16168490
[TBL] [Abstract][Full Text] [Related]
17. Peroxisome proliferator-activated receptor gamma in diabetes and metabolism.
Rangwala SM; Lazar MA
Trends Pharmacol Sci; 2004 Jun; 25(6):331-6. PubMed ID: 15165749
[TBL] [Abstract][Full Text] [Related]
18. Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets.
Brown JD; Plutzky J
Circulation; 2007 Jan; 115(4):518-33. PubMed ID: 17261671
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptors in vascular biology-molecular mechanisms and clinical implications.
Touyz RM; Schiffrin EL
Vascul Pharmacol; 2006 Jul; 45(1):19-28. PubMed ID: 16782410
[TBL] [Abstract][Full Text] [Related]
20. [Peroxisome proliferator activated nuclear receptors: possible role in the development of atherosclerosis].
Evdokimova MA; Zateĭshchikov DA; Sidorenko BA
Kardiologiia; 2003; 43(11):41-8. PubMed ID: 14671562
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]